National Institute of Neurological Disorders and Stroke (NINDS) - Authoritative resource on traumatic brain injury, stroke, neurodegenerative diseases, and the neuroscience of brain repair mechanisms
MeAgain sends a customizable shot reminder, shows the next-dose countdown on the home screen, and keeps the weekly rhythm visible inside the routine view
Special Populations Requiring Monitoring : Elderly patients may be more susceptible to gastrointestinal side effects and dehydration Patients taking insulin or sulfonylureas require dose adjustments of these medications to prevent hypoglycemia Patients with cardiovascular disease should be monitored, though cardiovascular outcomes data are still emerging Patients with depression or suicidal ideation (particularly for Zepbound) require careful monitoring for worsening symptoms Pediatric patients : Safety and efficacy have not been established in patients under 18 years of age Regarding renal function, no dose adjustment is required for patients with renal impairment, including those with end-stage renal disease
Disminucin de la produccin de glucagn: la semaglutida tambin reduce la produccin de glucagn, otra hormona producida por el pncreas
not detected
Alternative therapies Stem cell treatments: Mesenchymal stem cell injections increasingly used for joint injuries and arthritis
